Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) fell 5.7% on Monday following insider selling activity. The stock traded as low as $33.42 and last traded at $33.53. 1,226,691 shares changed hands during trading, a decline of 22% from the average session volume of 1,575,843 shares. The stock had previously closed at $35.54.
Specifically, CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total value of $7,044,568.70. Following the transaction, the chief executive officer now directly owns 9,557,283 shares of the company's stock, valued at $358,780,403.82. The trade was a 1.93 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Ryan Fukushima sold 3,500 shares of the firm's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $40.23, for a total transaction of $140,805.00. Following the completion of the transaction, the chief operating officer now owns 1,003,707 shares in the company, valued at $40,379,132.61. The trade was a 0.35 % decrease in their position. The disclosure for this sale can be found here. In other Tempus AI news, EVP Andrew Polovin sold 1,130 shares of Tempus AI stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $40.23, for a total transaction of $45,459.90. Following the transaction, the executive vice president now directly owns 244,955 shares of the company's stock, valued at $9,854,539.65. The trade was a 0.46 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. Piper Sandler restated a "neutral" rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price for the company. Stifel Nicolaus lowered Tempus AI from a "buy" rating to a "hold" rating and increased their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital boosted their price target on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Finally, Bank of America increased their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research report on Friday, December 13th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $56.00.
Read Our Latest Stock Report on Tempus AI
Tempus AI Stock Down 1.8 %
The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business's fifty day simple moving average is $51.12.
Institutional Investors Weigh In On Tempus AI
Hedge funds and other institutional investors have recently modified their holdings of the stock. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $30,000. Geode Capital Management LLC boosted its holdings in Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock worth $7,537,000 after purchasing an additional 539 shares during the period. Vestor Capital LLC bought a new stake in Tempus AI during the third quarter valued at $153,000. The Manufacturers Life Insurance Company raised its holdings in shares of Tempus AI by 10.2% during the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company's stock worth $1,686,000 after purchasing an additional 2,765 shares during the period. Finally, Stifel Financial Corp bought a new position in shares of Tempus AI in the 3rd quarter worth about $218,000. Institutional investors own 24.22% of the company's stock.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.